← Evidence map

ArticleFrontiers in pharmacology2022

A Novel PARP Inhibitor YHP-836 For the Treatment of BRCA-Deficiency Cancers.

Tingting Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35910366